Clinical trial Recruiting at 1 site Observational Ages 1 Year to 12

Effects of Remimazolam on Brain Activity in Children

Official title: Electroencephalogram Study in Children Under Remimazolam Anesthesia - a Prospective,Observational Study

Run by Second Affiliated Hospital of Wenzhou Medical University · NCT06698705 · Data updated 2026-11-12

This study looks at how a type of anesthesia called Remimazolam affects brain activity in children aged 1 to 12 years during surgery to help improve safety and monitoring.

Quick facts

Study typeObservational
Ages1 Year to 12 Years
SexAll
Enrollment60 (estimated)
SponsorSecond Affiliated Hospital of Wenzhou Medical University
Academic / other
Locations1 site (Wenzhou, Zhejiang)
StatusRecruiting
StartedNovember 22, 2024
Main results expectedDecember 1, 2025
Study endsDecember 1, 2025
Registry record updatedFebruary 6, 2025
Trial IDNCT06698705 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children aged 1 to 12 years requiring general anesthesia with Remimazolam and classified as ASA physical status I or II.

Probably not a fit

Patients with congenital malformations, severe medical conditions, or recent upper respiratory infections may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates how Remimazolam anesthesia affects brain electrical activity in children aged 1 to 12 years. Participants will be grouped by age and monitored for changes in electroencephalography (EEG) during anesthesia induction, maintenance, and recovery. The study aims to identify specific EEG patterns associated with Remimazolam, which may improve monitoring techniques for anesthesia depth in pediatric patients. Informed consent will be obtained from parents or legal guardians prior to participation.

Why it matters

Potential benefit: If successful, this study could enhance the safety and effectiveness of anesthesia monitoring in children.

How similar studies have gone: Previous studies have indicated specific EEG patterns during Remimazolam anesthesia in adults, suggesting potential for success in this pediatric population.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1\. aged 1 years-12 years; 2, with American Society of Anesthesiologists (ASA) physical status I or II; 3, children requiring general anesthesia under remimazolam; 4, parents or legal guardians of children who volunteered to participate in the trial; And signed the informed consent form.

Exclusion Criteria:

1. Congenital malformation or other genetic conditions that are thought to affect brain development ;
2. History of severe heart, brain, liver, kidney and metabolic diseases ;
3. Premature infants (≤32 weeks);
4. Upper respiratory tract infection in the last two weeks. -

Where it's running

  • The second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University
    Wenzhou, Zhejiang, China
    Recruiting

Study contacts

  • Principal investigator: Huacheng Liu — Second Affiliated Hospital of Wenzhou Medical University
  • Study coordinator: Huacheng Liu
  • Email: huachengliu@163.com
  • Phone: 13957770577

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.